Documente Academic
Documente Profesional
Documente Cultură
Prof.dr.Şerban Bubenek MD
Physiology of Cardiovascular System
• CO = SV x HR (Normal = 4.0 - 8.0 l/min)
MAP = CO x SVR
VO2 = DC ( CaO2-CvO2)
• The result is cellular dysoxia, i.e. the loss of the physiological independence
between oxygen delivery (DO2) and oxygen consumption (VO2), associated
with increased lactate levels !
SHOCK
PHYSIOPATHOLOGY
Shock= severe disequilibrium between DO2 and VO2
CvO2 CaO2
DO2
CaO2
VO2
SHOCK
1743 Henri Francois Le Dron
DO2 VO2
• SEPTIC SHOCK
– PRecharge ( hypovolemic S. )
CO CO
– Contractility (cardiogenic S. )
(a Hyperdinamic form of shock )
–- PR, Contr + Postcharge
(obstructive shock)
all
– 3 are hypodinamic forms of shock
+: the SKIN !
Hyperdinamic SHOCK= VO2
VO2 DO2
Cardiac
VO2 OUTPUT
O2
VO2 demand
s
RASPUNS LA AGRESIUNE MAJORA
1. Restabilirea stabilitatii cardio-vasculare
SCOP
2. Mentinerea aportului de O2 la nivel tisular
Raspuns: 3. Mobilizare substrat energetic
-Nespecific 4. Minimalizarea durerii
5. Vindecarea plagii
- Generalizat
a) Modif. VSCE
O2
b) Modif. conc. CO2
H+
c) Durere si emotie
d) Modif. Substratului
e) temperatura
f) Infectia
g) plaga
RSA
EFERENTE
I. Raspuns NEURO-ENDOCRIN
• T.R. vegetativ CATECOLAMINE
Rasp glucagon, insulina
endocrin
• Axa hipot-hipof cortizol
tiroxina
STH
vasopresina
Rasp CRF
umoral hipotal hipofiza ACTH
VIP endorfine
catecol. MSR
II. RASPUNS INFLAMATOR
eliberare peptide mici local
efect la distanta
SIRS systemic inflammatory response syndrome
Macrocirculaţie:
- activarea baroreceptorilor şi declanşarea reacţiei simpato-adrenergice (RSA) cu
eliberarea de catecolamine la nivelul terminaţiilor libere simpatice şi a
medulosuprarenalei.
în două etape:
Rezultate :
1 . creşterea eliberării de catecolamine care prin acţiune pe receptorii α-adrenergici vor produce intai
venoconstrictie apoi, arteriolo-constricţie iar pe β1 vor produce tahicardie, creşterea contractilitatii.
2. redistribuţia regională a fluxului sanguin (denumită în tratatele mai vechi „centralizarea circulaţiei”) dinspre organele
bogate în receptori alfa (splahne, muşchi scheletici, piele) înspre organele sărace în aceşti receptori (creier, cord)
3. activarea axului renină-angiotensina şi vasopresina vor creşte şi ele tonusul vasomotor, în special în patul vascular
mezenteric. (Angiotensina II va creşte eliberarea de aldosteron şi descărcările simpatice iar
Vasopresina va stimula atât eliberarera de catecolamine cât şi contractilitatea miocardică).
► macrocirculaţie:
3. Presiuni de umplere
- în şocul hipovolemic presiunile de umplere (PVC, PCP) sunt mult scăzute
- în şocul cardiogen acestea sunt mult crescute.
IC
I Normal II Congestie
(ml / min / m )
2
pulmonară
2,5
III Hipovolemie IV Insuficienţă
Cardiacă
Congestivă
0 18
PCP (mm Hg)
Definition SHOCK
Definition of shock :
- does not require the presence of hypotension.
- requires to prove “failure to deliver and/or utilize adequate amounts of O2”
and may include, but is not limited to, the presence of hypotension.
2014
1B
Perfusion markers
- it exists a critical level of DO2 when VO2 becomes dependent on DO2 and:
LACTATE ↑ and regional and microcirculatory perfusion is ↓
• duration and area under the curve of the increased blood lactate levels have been
related to morbidity and mortality in different groups of pts. and have a place in
risk-stratification
Jansen TC, van Bommel J, Bakker J: Crit Care Med 2009, 37(10):2827–39
Bakker J, Gris P, Coffernils M, Kahn RJ, Vincent JL: Am J Surg 1996, 171(2):221–26.
Jansen TC, van Bommel J, Woodward RG, Bakker J: Crit Care Med 2009, 37(8):2369–74
• in the early phase of resuscitation, lactate levels is more closely related to outcome
than frequently used haemodynamics, including DO2 or VO2.
Jansen TC, van Bommel J, Mulder PG, Rommes JH: Crit Care 2008, 12(6):R160.
Bakker J, Coffernils M, Leon M, Gris P, Vincent J-L: Chest 1991, 99(4):956–962.
Howell M, Donnino M, Clardy P, Talmor D, Shapiro N: Intensive Care Med 2007, 33(11):1892–99.
Shapiro NI, Howell MD, Talmor D, Nathanson LA, Wolfe R: Ann Emerg Med 2005,45(5):524-28
• the usual cut-off value is 2 mEq/L (or mmol/L), but lactate levels > 1.5 mmol/L in
patients with septic shock are associated with increased mortality
Wacharasint P, Nakada TA, Boyd JH, Russell JA, Walley KR: Shock, 2012, 38:4–10
Lactate, SvO2, ScvO2, ΔP(v-a)CO2
• We recommend arterial and CVC insertion in shock not responsive to initial
therapy and/or requiring vasopressor infusion. UG-BP
• Lactate levels are typically2 > mEq/L (or mmol/L) in shock states. SF
►microcirculaţie :
- ∆(a-v)O2 normală sau la limita de jos;
- flux sanguin circulator periferic crescut, dar maldistribuit.
REACTIA
SISTEMICA = RASPUNS
POSTAGRESIUNE – neurohumoral
– metabolic
– imunologic
– celular
specific
RASPUNS
AGRESIUNE nespecific – generalizat la o agresiune majora
– INFECTIA
– TRAUMA
– HEMORAGIE – HIPOVOLEMIE
– ARSURA
– ISCHEMIE PRELUNGITA
– INTERV. CHIRURGICALA
stereotip
RASPUNS generalizat
nespecific
• central
• periferic
•
~ amploarea agresiunii
SEPTIC SHOCK
• ACTIVATORI
• MEDIATORI
Elementele umorale ale raspunsului inflamator
March 2016
- Sepsis need greater levels of monitoring, intervention and possible ICU admission.
Results/Recommendations (2)
Clinical Criteria to Identify Patients With Sepsis
• the baseline SOFA score should be assumed to be 0 unless the patient is known to
have preexisting (acute or chronic) organ dysfunction before the onset of infection
• pts. with a SOFA score of ≥ 2 had an overall mortality risk of approximately 10% in
a general hospital population with presumed infection ( vs 8.1 % in STEMI ! )
Adult pts. with septic shock can be identified using the clinical criteria:
SEPSIS
and
• hypotension requiring vasopressors to maintain MAP≥65mmHg
and
• serum lactate level >2 mmol/L after adequate fluid resuscitation
• adult patients with suspected infection can be rapidly identified as being more
likely to have poor outcomes typical of sepsis if they have:
namely:
IC
I Normal II Congestie
(ml / min / m )
2
pulmonară
2,5
III Hipovolemie IV Insuficienţă
Cardiacă
Congestivă
0 18
PCP (mm Hg)
TRATAMENT SOC HIPOVOLEMIC
Restabilire DO2
1. VOLEMIE
2. Transportor (Hb) PULM
3. Optimizare functie
4. trat. reologic CARDIACA
Restabilire DO2 DC
1. Mentinerea TAS NORADRENALINA
2. Trat. etiologic IMac
Valv
DSV
TR
Tamponada
embolie pulm
3. Trat. asociat
TRATAMENT SOC SEPTIC
1. TRAT. ETIOLOGIC
— plaga, trauma, arsura
— focar septic
— antibiotice
— Ac monoclonali
2. Trat. PATOGENIC
• Proteina C activata
• CORTIZON
• CYTOSORBENTS !
• Vitamin K ?
3. Trat. la nivel ORGAN – SISTEM
OPTIMIZARE FUNCTIE
— Cardiovasculara
— Pulmonara
— Renala
— Metabolica
— Nutritie
PROTEZARE
m
• m
74 pages , 655 references: only for ADULTS
NEW
NEW
!
I.BLOOD PRODUCTS
J. IMMUNOGLOBULINS
K. BLOOD PURIFICATION
L. ANTICOAGULANTS
M. MECHANICAL VENTILATION
Q. BICARBONATE THERAPY
T. NUTRITION
I. R. anafilactica = interactiune Ag – Ac
II. R. anafilactoida = eliberare directa de mediator din mastocit
Clinic – LA FEL!
FIZIOPAT.
Complex Ag – Ac (IgE)
sau activare
direct Mastocit
Bazofil
Elib. MEDIATORI
PRIMARI / SEC
AMPc
GMPc
SOCUL ANAFILACTIC
Med primari
– HISTAMINA
– compl SRSA
– PAF, PG, LTB4
Med secundari
– C3a, C5a
– C7a + C8a + C9a = C. ATAC
– f XIIa
– Kinine- ~
CLINIC sever!
Dispnee, Eruptie, Angioedem
Bronhospasm – hTA – EPA
ACIDOZA LACTICA Soc hipovolemic STOP CR
• hipovolemie
• vasodilatatie
• contract. mioc.
• modif. permeab. PULM
Tratament 1. Terapie respiratorie
2. catecolamine / ADRE !!!
3. hipovolemie
4. antihistaminice
5. cortizon
SOCUL NEUROGEN
TRAUMA SNC
Cauza hTA
RAHIANESTEZIE
SIMPATICOLIZA
↓RVS
↑DC
MALDISTRIBUŢIE A EXTRACARDIAC
MICROCIRCULAŢIEI ↓DC OBSTRUCTIV
↑RVS
DISTRIBUTIV
↓PAM
HIPOPERFUZIE ↓ PERFUZIA
TISULARĂ DEPRESIE CORONARIANĂ
MIOCARDICĂ
ŞOC
INJURIE
CELULARĂ CARDIOGEN
MICROTROMBOZE
MODS
CLEARANCE-UL
TOXICELOR
ACIDOZA
MEDIATORI
Leziuni ale
barierei intestinale